Home Catamaran Bio

Catamaran Bio

In operation
Series A
Biological New Drug Developer for Cancer Treatment

Basic Information

Catamaran Bio is committed to realizing the full potential of cell therapy by empowering a key type of immune cell, natural killer (NK) cells, to exhibit new properties and create transformative cancer treatments for more patients. Through synthetic biology and non-viral cell engineering technology, Catamaran Bio has developed allogeneic CAR-NK cell therapies to treat cancer.
Catamaran Bio, Inc.
Cambridge,Massachusetts,United States of America
15~50 people
January 01, 2020
opportunities@catamaranbio.com